PD48-07: Pivotal Study Evaluating Performance of Bladder EpiCheck, an FDA cleared test, in Non-Muscle Invasive Bladder Cancer

PD48-07: Pivotal Study Evaluating Performance of Bladder EpiCheck, an FDA cleared test, in Non-Muscle Invasive Bladder Cancer

Sunday, May 5, 2024 2:00 PM to 2:10 PM · 10 min. (US/Central)
304A
Delete

Registered attendees

Max Kates
Max Kates
Director, Division of Urologic OncologyJohns Hopkins Hospital

Log in